US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
NR

NRXSStock

NYSE American · Healthcare · US

$6.93
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment NRXS's does — no target price to set, unlike "Alert" above.

Sharia status
NOT YET SCREENED
Not screened yet — no methodology has been established for this symbol
0 of 3 pass our own screen — 4 of 7 could not be computed
HTR non-permissible income 0.06%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

EMA_PULL · SCALP
Entry
$5.89
Stop
$5.82
Target
$6.03
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 91.3% aligned
VWAPPrice below VWAP ($6.96)
VolumeRelative volume 1.6× the 20-day average
Momentum10-day rate of change -8.4%
Market & analysts
Price target
$11.00
+58.7% · 2 analysts
Institutional own.
28.4%
of shares
Momentum (10d)
-8.4%
rate of change
SMC grade
B · 72
91.3% aligned
0.00% *
Purification ratio (secondary provider, uncertain)
0.06%
Non-permissible income — HTR, from filings (2025-12-31)
B · 72
SMC grade — 91.3% timeframe alignment
-8.4%
Rate of change (10d)
$11.00
Price target (+58.7%) · 2 analysts
28.4%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-06-30. NRXS files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Unverified⚠️ implied interest rate too high — debt may be understated

RatioValueThresholdResult
Interest-bearing debt 0.37% 30.00% Pass
Interest-bearing investments 11.12% 30.00% Pass
Non-permissible income 0.06% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 2.79% 33.00% Pass
Interest-bearing investments 83.25% 33.00% Fail
Non-liquid assets 12.41% at least 20.00% Fail
Non-permissible income 0.06% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 2.79% 33.33% Pass
Cash + interest-bearing securities 83.25% 33.33% Fail
Accounts receivable 87.59% 33.33% Fail
Non-permissible income 0.06% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 0.43% 33.33% Pass
Cash + interest-bearing securities 83.25% 33.33% Fail
Accounts receivable 87.59% 50.00% Fail
Non-permissible income 0.06% 5.00% Pass

Dow Jones Islamic Market Unverified⚠️ implied interest rate too high — debt may be understated

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.73% 33.00% Pass
Cash + interest-bearing securities 21.67% 33.00% Pass
Accounts receivable 1.13% 33.00% Pass
Non-permissible income 0.06% 5.00% Pass

S&P Shariah Unverified⚠️ implied interest rate too high — debt may be understated

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.87% 33.00% Pass
Cash + interest-bearing securities 26.05% 49.00% Pass
Accounts receivable 1.36% 49.00% Pass
Non-permissible income 0.06% 5.00% Pass

MSCI M-Series Unverified⚠️ implied interest rate too high — debt may be understated

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.87% 33.33% Pass
Cash + interest-bearing securities 26.05% 33.33% Pass
Accounts receivable 27.41% 49.00% Pass
Non-permissible income 0.06% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)non permissible income ratio 4.9pts
MSCI Islamic Index (% of total assets)non permissible income ratio 4.9pts
FTSE Shariah Global Equity Index Series (% of total assets)non permissible income ratio 4.9pts
MSCI Islamic Index (% of total assets)receivables ratio 54.3pts
Usmani (% of total assets)investments ratio 50.3pts
MSCI Islamic Index (% of total assets)cash and interest ratio 49.9pts

The numbers the ratios are built from

Read from NRXS's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $3.6M 2025-12-31 Revenues
Interest-bearing debtShort and long-term borrowings $42.7K 2026-06-30 ShortTermBorrowings
Cash and interest-bearing securitiesCash, equivalents and marketable securities $8.3M 2026-06-30 CashAndCashEquivalentsAtCarryingValue
Total assetsBalance sheet total $10.0M 2026-06-30 Assets
Market capDenominator for AAOIFI $74.8M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $32.5M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $40.1M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $2.1K 2025-12-31 InterestAndOtherIncome

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for NRXS. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for NRXS has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

ℹ️ no compliance scan has run for 3 days - this is not a reading of today

8.817.195.563.942.312025-10-132026-04-142026-10-09

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
6.31
S2
6.49
S1
6.63
PIVOT
6.81
R1
6.95
R2
7.13
R3
7.27

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
5.87 – 8.93
±20.62% from 7.40, made 2026-09-30 · resolves 2026-10-07
STRONG BUY
from 19 indicators
61.9% of our last 5789 forecasts landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

BUY
19 indicators
OscillatorsSTRONG SELL
0 buy · 4 neutral · 3 sell
Moving averagesSTRONG BUY
8 buy · 0 neutral · 4 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)50.90NEUTRAL
Stochastic %K (14)22.76NEUTRAL
CCI (20)-35.10NEUTRAL
Williams %R (14)-77.24NEUTRAL
MACD (12,26,9)-0.08SELL
ROC (10)-8.33SELL
Momentum (10)-0.63SELL
EMA (10)7.01SELL
SMA (10)7.13SELL
EMA (20)6.95SELL
SMA (20)7.10SELL
EMA (30)6.86BUY
SMA (30)6.69BUY
EMA (50)6.78BUY
SMA (50)6.58BUY
EMA (100)6.66BUY
SMA (100)6.78BUY
EMA (200)5.94BUY
SMA (200)6.45BUY

About NRXS

Healthcare · Biotechnology

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

neuraxis.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-14

EMA_PULL
Type · SCALP
5.89
Entry
5.82
Stop
6.03
Target
LOSS
Outcome

Stop 5.82 Now 6.93 Target 6.03

Grade verdict

Good setup, solid confluence

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 21
🕐 1H BEARISH 87
⏱ 15-Min BULLISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-8.4%
Rate of change (10d)
1.6×
Volume vs its 20-day average
0.12
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-10-06 · Asset managers net 906615 (+2612)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.